New 52 Week Low Today

Prothena Corporation PLC PRTA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:44 AM EDT
24.43quote price arrow down-0.73 (-2.88%)
Volume
158,645
52 week range
24.25 - 79.65
Loading...
  • Open25.25
  • Day High25.34
  • Day Low24.25
  • Prev Close25.16
  • 52 Week High79.65
  • 52 Week High Date05/05/23
  • 52 Week Low24.25
  • 52 Week Low Date03/28/24

Key Stats

  • Market Cap1.313B
  • Shares Out53.72M
  • 10 Day Average Volume0.68M
  • Dividend-
  • Dividend Yield-
  • Beta0.21
  • YTD % Change-33.08

KEY STATS

  • Open25.25
  • Day High25.34
  • Day Low24.25
  • Prev Close25.16
  • 52 Week High79.65
  • 52 Week High Date05/05/23
  • 52 Week Low24.25
  • 52 Week Low Date03/28/24
  • Market Cap1.313B
  • Shares Out53.72M
  • 10 Day Average Volume0.68M
  • Dividend-
  • Dividend Yield-
  • Beta0.21
  • YTD % Change-33.08

RATIOS/PROFITABILITY

  • EPS (TTM)-2.80
  • P/E (TTM)-8.73
  • Fwd P/E (NTM)-5.01
  • EBITDA (TTM)-190.108M
  • ROE (TTM)-24.85%
  • Revenue (TTM)91.37M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-160.91%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date04/29/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Prothena Corporation PLC

 

Profile

MORE
Prothena Corporation plc is an Ireland-based late-stage clinical biotechnology company. The Company is engaged in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid diseases. The Company is advancing a pipeline of therapeutic candidates for a range of indications and targets to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins. The Company’s pipeline includes both wholly owned and...
Lars Ekman M.D., Ph.D.
Independent Chairman of the Board
Gene Kinney Ph.D.
President, Chief Executive Officer, Director
Brandon Smith
Chief Operating Officer
Tran Nguyen
Chief Financial Officer, Chief Strategy Officer
Karin Walker CPA
Chief Accounting Officer
Address
77 Sir John Rogersons Quay
Block C, Grand Canal Docklands
Dublin
D02 T804
Ireland

Top Peers

SYMBOLLASTCHG%CHG
VIR
Vir Biotechnology Inc
10.07-0.03-0.25%
RCUS
Arcus Biosciences Inc
18.76+0.55+3.02%
SAGE
SAGE Therapeutics Inc
18.67-0.37-1.94%
ABCL
Abcellera Biologics Inc
4.54+0.05+1.22%
LGND
Ligand Pharmaceuticals Inc
71.59+0.33+0.46%